Medindia

SYMBICORT® (budesonide/formoterol fumarate dihydrate) Study in African American Patients With Asthma Shows Improved Lung Function Compared to Budesonide Alone

TITAN study results presented at CHEST meeting represent one of few asthma studies to examine African American patients exclusively SYMBICORT is a combination asthma medication that contains both an ...
Fierce Healthcare

SYMBICORT® (budesonide/formoterol fumarate dihydrate) Long-Term Study Shows Similar Safety Profile When Compared to

WILMINGTON, Del.--(BUSINESS WIRE)-- AstraZeneca (NYSE:AZN) today announced the publication of data demonstrating that SYMBICORT Inhalation Aerosol 320/9 µg twice daily had a safety profile similar to ...
FiercePharma

Long-Term Study Demonstrates Safety and Efficacy of SYMBICORT® in African American Patients with Asthma

DENVER--(BUSINESS WIRE)-- AstraZeneca (NYSE:AZN) today announced results from a long-term study comparing SYMBICORT ® (budesonide/ formoterol fumarate dihydrate) Inhalation Aerosol 160/4.5 mcg with ...
FierceBiotech

Press Release: AstraZeneca Announces Symbicort Is Now Available In The U.S.

AstraZeneca Announces Symbicort Is Now Available In The U.S. U.S. Asthma Sufferers Now Have a New Choice of Combination Therapy to Help Achieve Asthma Control LONDON ...
Seeking Alpha

AstraZeneca's Symbicort successful in two late-stage studies for expanded use

AstraZeneca (NYSE:AZN) announces successful results from two clinical trials assessing the expanded use of SYMBICORT (budesonide/formoterol fumarate dihydrate ...
News Medical

Symbicort Rapihaler

The full CMI on the next page has more details. If you are worried about using this medicine, speak to your doctor or pharmacist. Symbicort Rapihaler contains two active ingredients in one inhaler: ...
Monthly Prescribing Reference

FDA Approves Inhaler Monitoring Device for Symbicort

The SmartTouch for Symbicort is a monitoring device that is installed onto the patient's inhaler to track and improve medication adherence. The Food and Drug Administration (FDA) has granted Adherium ...
Monthly Prescribing Reference

Digital Health Tool Propeller Cleared for Use With Symbicort Inhaler

The Food and Drug Administration (FDA) has cleared the Propeller Health digital platform to connect with the Symbicort® Inhaler (budesonide, formoterol fumarate dihydrate; AstraZeneca), a ...
FierceBiotech

EPO Announces Symbicort European COPD Use Patent Decision

AstraZeneca today announced that the European Patent Office (EPO) Technical Board of Appeal has made a final ruling that the European Combination patent covering the use of Symbicort (formoterol and ...
Business Insider

Symbicort® Turbuhaler® now approved by Health Canada for use in mild persistent, moderate, or severe asthma

MISSISSAUGA, ON, Sept. 30, 2019 /CNW/ - AstraZeneca Canada announced today that Health Canada has approved the expanded use of Symbicort ® Turbuhaler ® (budesonide ...
Nursing in Practice

Practice dilemma: How can I step up a child’s asthma treatment when licensed MART is not an option?

How to step up asthma treatment in a child who can't use a dry powder inhaler (DPI) licensed for Maintenance and Reliever ...
FiercePharma

SYMBICORT® (budesonide/formoterol fumarate dihydrate) Study in African American Patients With Asthma Shows Improved Lung Functio

(Logo: http://www.newscom.com/cgi-bin/prnh/20091027/PH99766LOGO) SYMBICORT is a combination asthma medication that contains both an inhaled corticosteroid (ICS ...